Cobalt-Nanoparticles Catalyzed Efficient and Selective Hydrogenation of Aromatic Hydrocarbons
作者:Kathiravan Murugesan、Thirusangumurugan Senthamarai、Ahmad S. Alshammari、Rashid M. Altamimi、Carsten Kreyenschulte、Marga-Martina Pohl、Henrik Lund、Rajenahally V. Jagadeesh、Matthias Beller
DOI:10.1021/acscatal.9b02193
日期:2019.9.6
catalysts for such reactions. The specific nanoparticles were prepared by assembling cobalt-pyromellitic acid-piperazine coordination polymer on commercial silica and subsequent pyrolysis. Applying the optimal nanocatalyst, industrial bulk, substituted, and functionalized arenes as well as polycyclic aromatic hydrocarbons are selectively hydrogenated to obtain cyclohexane-based compounds under industrially
[EN] HETEROARYL-UREAS AND THEIR USE AS GLUCOKINASE ACTIVATORS<br/>[FR] HETEROARYL-UREES ET LEUR UTILISATION EN TANT QU'ACTIVATEURS DE GLUCOKINASE
申请人:NOVO NORDISK AS
公开号:WO2005066145A1
公开(公告)日:2005-07-21
This invention relates to compounds that are of formula (I) wherein A is heteroaryl and R1 and R2 are both cyclic residues, that are activators of glucokinase and thus may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial .
Heteroaryl-Ureas and Their Use as Glucokinase Activators
申请人:Murray Anthony
公开号:US20090216013A1
公开(公告)日:2009-08-27
This invention relates to compounds of formula (I)
which are activators of glucokinase and thus may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial.
Dicycloalkylcarbamoyl Ureas As Glucokinase Activators
申请人:Murray Anthony
公开号:US20080319028A1
公开(公告)日:2008-12-25
This invention relates to dicycloalkylcarbamoyl ureas of formula (I), which are activators of glucokinase and thus may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial.
Heteroaryl-ureas and their use as glucokinase activators
申请人:Murray Anthony
公开号:US20070054897A1
公开(公告)日:2007-03-08
This invention relates to compounds of formula (I)
which are activators of glucokinase and thus may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial.